Duraflo II Heparin Treated Suction Wands Var. Mod.
by Baxter Bentley Laboratories, Inc.
510(k) K905311
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK905311 | Date15 Jan 1991 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DWD
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.4430
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Duraflo II Heparin Treated Suction Wands Variable Modification is an intracardiac suction control device designed for use during cardiopulmonary bypass procedures. It is classified as a Class II medical device under 21 CFR 870.4430 and is intended for controlled aspiration of fluids within the cardiovascular system, reducing the risk of clotting and improving surgical efficiency.
These suction wands are heparin-treated to minimize clotting during use and are supplied as a reusable device. They are intended for use in sterile operating room environments and must comply with MRI safety standards as applicable. The variable modification allows for adaptability to different surgical requirements, and the device is authorized under FDA 510(k) clearance K905311, with a decision date of January 15, 1991.